Key Takeaways
- • Brookfield Asset Management and Healthpeak Properties formed a $2.1 billion strategic joint venture involving 86 outpatient medical office buildings across 11 U.S. states, with Healthpeak retaining 51% controlling interest and Brookfield holding 49% non-controlling stake.
- • Healthpeak received approximately $1.025 billion in gross proceeds from the sale of its 49% interest, implying a trailing cash capitalization rate of 5.9% and a valuation of approximately $380 per square foot for the 5.6 million square foot portfolio.
- • The portfolio is 95% leased with a weighted-average remaining lease term of six years, diversified across Kentucky, Indiana, Pennsylvania, Arkansas, Illinois, Minnesota, New Jersey, and New York.
- • Healthpeak retained operational control as managing member, providing asset management, leasing, and property management services, while the venture will be consolidated on Healthpeak's financial statements with Brookfield's investment shown as non-controlling equity.
- • Healthpeak secured a call right beginning after year seven to repurchase Brookfield's interest at a price guaranteeing Brookfield a 6.5% net annual rate of return, providing long-term capital while preserving future value participation.
Summary
Healthpeak Properties and Brookfield Asset Management announced the formation of a long-term strategic capital partnership through a joint venture focused on a diversified portfolio of outpatient medical office buildings across the United States. The transaction, structured around a $2.1 billion portfolio valued at approximately $380 per square foot, represents a significant capital deployment in the healthcare real estate sector.
The portfolio consists of 86 properties totaling approximately 5.6 million square feet, geographically diversified across 11 states including Kentucky, Indiana, Pennsylvania, Arkansas, Illinois, Minnesota, New Jersey, and New York. The asset quality is underscored by a 95% occupancy rate and a weighted-average remaining lease term of six years, providing stable cash flow characteristics for both partners.
The capital structure reflects Healthpeak's dual objectives of securing long-term financing while retaining operational upside. Healthpeak retained a 51% controlling interest and serves as managing member, responsible for asset management, leasing, and property management services. Brookfield holds a 49% non-controlling interest. From the transaction, Healthpeak received approximately $1.025 billion in gross proceeds from the sale of its 49% stake, implying a trailing cash capitalization rate of 5.9%.
The venture will be consolidated on Healthpeak's financial statements, with Brookfield's investment recognized as non-controlling equity interest. Critically, Healthpeak secured a call right beginning after year seven, allowing the REIT to repurchase Brookfield's interest at a price providing Brookfield with a 6.5% net annual rate of return. This structure enables Healthpeak to participate in long-term portfolio appreciation while providing Brookfield with downside protection and return certainty.
The transaction addresses Healthpeak's capital needs while preserving ownership and operational control of core medical office assets in a market segment where stable lease terms and healthcare delivery demand remain foundational to valuations.
The portfolio consists of 86 properties totaling approximately 5.6 million square feet, geographically diversified across 11 states including Kentucky, Indiana, Pennsylvania, Arkansas, Illinois, Minnesota, New Jersey, and New York. The asset quality is underscored by a 95% occupancy rate and a weighted-average remaining lease term of six years, providing stable cash flow characteristics for both partners.
The capital structure reflects Healthpeak's dual objectives of securing long-term financing while retaining operational upside. Healthpeak retained a 51% controlling interest and serves as managing member, responsible for asset management, leasing, and property management services. Brookfield holds a 49% non-controlling interest. From the transaction, Healthpeak received approximately $1.025 billion in gross proceeds from the sale of its 49% stake, implying a trailing cash capitalization rate of 5.9%.
The venture will be consolidated on Healthpeak's financial statements, with Brookfield's investment recognized as non-controlling equity interest. Critically, Healthpeak secured a call right beginning after year seven, allowing the REIT to repurchase Brookfield's interest at a price providing Brookfield with a 6.5% net annual rate of return. This structure enables Healthpeak to participate in long-term portfolio appreciation while providing Brookfield with downside protection and return certainty.
The transaction addresses Healthpeak's capital needs while preserving ownership and operational control of core medical office assets in a market segment where stable lease terms and healthcare delivery demand remain foundational to valuations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.